Highlights Cara Therapeutics, Inc.

Equities

CARA

US1407551092

Market Closed - Nasdaq Other stock markets 04:00:00 2024-06-05 pm EDT			5-day change	1st Jan Change
0.6951 ^USD	+4.72%		+12.68%	-6.45%

May. 13	Earnings Flash (CARA) CARA THERAPEUTICS Posts Q1 Revenue $2.1M, vs. Street Est of $1.7M	MT
May. 13	Cara Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Earnings Flash (CARA) CARA THERAPEUTICS Posts Q1 Revenue $2.1M, vs. Street Est of $1.7M	May. 13	MT
Cara Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 13	CI
Cara Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	Mar. 04	CI
Earnings Flash (CARA) CARA THERAPEUTICS Reports Q4 Revenue $3M, vs. Street Est of $9.1M	Mar. 04	MT
North American Morning Briefing : Stock Futures -2-	Mar. 04	DJ
Cara Therapeutics, Inc. Prioritizes Late-Stage Notalgia Paresthetica Program	Jan. 22	CI
Cara Therapeutics, Inc. Announces Outcome from Dose- Finding Part A of the KIND 1 Study Evaluating Oral Difelikefalin for Mod Moderate-To-Severe Pruritus in Patients with Atopic Dermatitis	Dec. 18	CI
Cara Therapeutics Q3 Loss Widens, Revenue Drops	Nov. 13	MT
Earnings Flash (CARA) CARA THERAPEUTICS Posts Q3 Revenue $4.9M, vs. Street Est of $9.9M	Nov. 13	MT
Cara Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 13	CI
Cara Therapeutics Says Partner Receives Approval of Korsuva Injection to Treat Pruritus in Hemodialysis Patients in Japan	23-09-25	MT
Cara Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-07	CI
Earnings Flash (CARA) CARA THERAPEUTICS Reports Q2 Revenue $6.9M, vs. Street Est of $6.7M	23-08-07	MT
Vifor Fresenius Medical Care Renal Pharma and Cara Therapeutics, Inc. Announces England’s National Institute for Health and Care Excellence has Recommended Kapruvia	23-05-18	CI
Cara Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-15	CI
Earnings Flash (CARA) CARA THERAPEUTICS Reports Q1 Revenue $6.2M, vs. Street Est of $4.98M	23-05-15	MT
Cara Therapeutics Q4 Net Loss Narrows as Revenue Rises But Results Still Trail Expectations -- Shares Fall Pre-Bell	23-03-07	MT
Cara Therapeutics Q4 Net Loss Narrows, Revenue Rises; Results Trail Estimates; Shares Slump	23-03-06	MT
Earnings Flash (CARA) CARA THERAPEUTICS Posts Q4 Revenue $3.3M, vs. Street Est of $14.5M	23-03-06	MT
Cara Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-06	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Cara Therapeutics, Inc.

Equities

CARA

US1407551092

Highlights

Filters